Overweight,Obesity: Clinical Trials

2 trials for Overweight,Obesity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1

Follow Overweight,Obesity: new trials by email Literature Review of Overweight,Obesity trials Research Report on Overweight,Obesity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants
ZT002 injection, metformin, warfarin, ZT002 injection, rosuvastatin, digoxin - Overweight,Obesity
Phase 1Active not recruitingBeijing QL Biopharmaceutical Co.,Ltd602026-05-272026-10-21
Dose-escalation and Food Effect Study of ZT006 in Healthy, Overweight and Obese Participants
ZT006, Placebo of ZT006 - Overweight,Obesity
Phase 1CompletedBeijing QL Biopharmaceutical Co.,Ltd942024-11-282025-12-29

Narrower conditions

Obesity (2)  ·  Overweight (2)

Broader conditions

Body Weight (2)  ·  Nutrition Disorders (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Overnutrition (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)

Interventions

Digoxin (1)  ·  Metformin (1)  ·  Rosuvastatin Calcium (1)  ·  Warfarin (1)

Sponsors

Beijing QL Biopharmaceutical Co.,Ltd (2)

Countries

China (2)

Top investigators

Qin Yu, Master (1)  ·  Wei Hu, MD (1)  ·  Yijun Du, Master (1)